GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TFDP1
|
ENSG00000198176.8 | transcription factor Dp-1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TFDP1 | hg19_v2_chr13_+_114238997_114239077 | 0.64 | 6.3e-27 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_27022839 | 87.07 |
ENST00000457599.2
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
chr6_-_86352982 | 79.95 |
ENST00000369622.3
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
chr17_-_73179046 | 59.63 |
ENST00000314523.7
ENST00000420826.2 |
SUMO2
|
small ubiquitin-like modifier 2 |
chr11_+_85955787 | 53.05 |
ENST00000528180.1
|
EED
|
embryonic ectoderm development |
chr17_-_73178599 | 50.79 |
ENST00000578238.1
|
SUMO2
|
small ubiquitin-like modifier 2 |
chrX_-_16887963 | 47.90 |
ENST00000380084.4
|
RBBP7
|
retinoblastoma binding protein 7 |
chr1_+_43148625 | 47.83 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
chr17_+_34900737 | 47.45 |
ENST00000304718.4
ENST00000485685.2 |
GGNBP2
|
gametogenetin binding protein 2 |
chrX_+_64887512 | 44.74 |
ENST00000360270.5
|
MSN
|
moesin |
chr1_+_62902308 | 43.59 |
ENST00000339950.4
|
USP1
|
ubiquitin specific peptidase 1 |
chr1_+_29063119 | 42.34 |
ENST00000474884.1
ENST00000542507.1 |
YTHDF2
|
YTH domain family, member 2 |
chr1_+_26798955 | 41.94 |
ENST00000361427.5
|
HMGN2
|
high mobility group nucleosomal binding domain 2 |
chr1_+_29063439 | 41.10 |
ENST00000541996.1
ENST00000496288.1 |
YTHDF2
|
YTH domain family, member 2 |
chr4_-_83350580 | 40.90 |
ENST00000349655.4
ENST00000602300.1 |
HNRNPDL
|
heterogeneous nuclear ribonucleoprotein D-like |
chr17_+_37026106 | 40.78 |
ENST00000318008.6
|
LASP1
|
LIM and SH3 protein 1 |
chr17_+_37026284 | 40.46 |
ENST00000433206.2
ENST00000435347.3 |
LASP1
|
LIM and SH3 protein 1 |
chr6_-_86352642 | 39.13 |
ENST00000355238.6
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
chr17_-_4852332 | 38.55 |
ENST00000572383.1
|
PFN1
|
profilin 1 |
chr1_+_29063271 | 38.41 |
ENST00000373812.3
|
YTHDF2
|
YTH domain family, member 2 |
chr16_+_67596310 | 36.17 |
ENST00000264010.4
ENST00000401394.1 |
CTCF
|
CCCTC-binding factor (zinc finger protein) |
chr1_+_110881945 | 35.57 |
ENST00000602849.1
ENST00000487146.2 |
RBM15
|
RNA binding motif protein 15 |
chr17_-_4852243 | 35.34 |
ENST00000225655.5
|
PFN1
|
profilin 1 |
chr4_+_57301896 | 34.62 |
ENST00000514888.1
ENST00000264221.2 ENST00000505164.1 |
PAICS
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
chr1_+_43148059 | 34.23 |
ENST00000321358.7
ENST00000332220.6 |
YBX1
|
Y box binding protein 1 |
chr2_+_172778952 | 33.69 |
ENST00000392584.1
ENST00000264108.4 |
HAT1
|
histone acetyltransferase 1 |
chr12_-_57081940 | 33.08 |
ENST00000436399.2
|
PTGES3
|
prostaglandin E synthase 3 (cytosolic) |
chrX_-_16888448 | 32.73 |
ENST00000468092.1
ENST00000404022.1 ENST00000380087.2 |
RBBP7
|
retinoblastoma binding protein 7 |
chr4_-_174255536 | 32.24 |
ENST00000446922.2
|
HMGB2
|
high mobility group box 2 |
chr6_-_17706618 | 32.07 |
ENST00000262077.2
ENST00000537253.1 |
NUP153
|
nucleoporin 153kDa |
chr6_+_34204642 | 31.77 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
chr3_-_113465065 | 30.78 |
ENST00000497255.1
ENST00000478020.1 ENST00000240922.3 ENST00000493900.1 |
NAA50
|
N(alpha)-acetyltransferase 50, NatE catalytic subunit |
chr12_-_31479045 | 29.41 |
ENST00000539409.1
ENST00000395766.1 |
FAM60A
|
family with sequence similarity 60, member A |
chr16_+_67063036 | 29.13 |
ENST00000290858.6
ENST00000564034.1 |
CBFB
|
core-binding factor, beta subunit |
chr1_+_27022485 | 28.94 |
ENST00000324856.7
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
chr13_-_31039375 | 28.38 |
ENST00000399494.1
|
HMGB1
|
high mobility group box 1 |
chr4_-_83351005 | 28.33 |
ENST00000295470.5
|
HNRNPDL
|
heterogeneous nuclear ribonucleoprotein D-like |
chr16_+_67063142 | 28.28 |
ENST00000412916.2
|
CBFB
|
core-binding factor, beta subunit |
chr9_+_131451480 | 28.16 |
ENST00000322030.8
|
SET
|
SET nuclear oncogene |
chr11_-_46142948 | 27.96 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
chr13_-_31040060 | 27.61 |
ENST00000326004.4
ENST00000341423.5 |
HMGB1
|
high mobility group box 1 |
chr16_-_50402690 | 27.13 |
ENST00000394689.2
|
BRD7
|
bromodomain containing 7 |
chr16_-_50402836 | 26.52 |
ENST00000394688.3
|
BRD7
|
bromodomain containing 7 |
chr11_-_46142615 | 26.18 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
chrX_-_129244655 | 26.02 |
ENST00000335997.7
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
chr17_-_61920280 | 25.75 |
ENST00000448276.2
ENST00000577990.1 |
SMARCD2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
chr1_-_183604794 | 25.37 |
ENST00000367534.1
ENST00000359856.6 ENST00000294742.6 |
ARPC5
|
actin related protein 2/3 complex, subunit 5, 16kDa |
chr7_-_72936531 | 25.20 |
ENST00000339594.4
|
BAZ1B
|
bromodomain adjacent to zinc finger domain, 1B |
chr17_+_45728427 | 24.93 |
ENST00000540627.1
|
KPNB1
|
karyopherin (importin) beta 1 |
chr4_-_103748696 | 24.90 |
ENST00000321805.7
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr1_-_32403903 | 24.85 |
ENST00000344035.6
ENST00000356536.3 |
PTP4A2
|
protein tyrosine phosphatase type IVA, member 2 |
chr19_+_16222439 | 24.72 |
ENST00000300935.3
|
RAB8A
|
RAB8A, member RAS oncogene family |
chr20_-_49547731 | 24.45 |
ENST00000396029.3
|
ADNP
|
activity-dependent neuroprotector homeobox |
chr20_+_35234137 | 24.37 |
ENST00000344795.3
ENST00000373852.5 |
C20orf24
|
chromosome 20 open reading frame 24 |
chr9_-_35103105 | 24.34 |
ENST00000452248.2
ENST00000356493.5 |
STOML2
|
stomatin (EPB72)-like 2 |
chr17_-_38574169 | 23.84 |
ENST00000423485.1
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa |
chr2_-_61765315 | 23.49 |
ENST00000406957.1
ENST00000401558.2 |
XPO1
|
exportin 1 (CRM1 homolog, yeast) |
chr6_+_47445467 | 23.47 |
ENST00000359314.5
|
CD2AP
|
CD2-associated protein |
chr6_-_52149475 | 23.22 |
ENST00000419835.2
ENST00000229854.7 ENST00000596288.1 |
MCM3
|
minichromosome maintenance complex component 3 |
chr16_-_87903079 | 23.16 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
chr20_+_35234223 | 22.95 |
ENST00000342422.3
|
C20orf24
|
chromosome 20 open reading frame 24 |
chr19_+_39138320 | 22.74 |
ENST00000424234.2
ENST00000390009.3 ENST00000589528.1 |
ACTN4
|
actinin, alpha 4 |
chr9_+_36572851 | 22.65 |
ENST00000298048.2
ENST00000538311.1 ENST00000536987.1 ENST00000545008.1 ENST00000536860.1 ENST00000536329.1 ENST00000541717.1 ENST00000543751.1 |
MELK
|
maternal embryonic leucine zipper kinase |
chr18_-_48723690 | 22.59 |
ENST00000406189.3
|
MEX3C
|
mex-3 RNA binding family member C |
chr14_-_75643296 | 22.29 |
ENST00000303575.4
|
TMED10
|
transmembrane emp24-like trafficking protein 10 (yeast) |
chrX_+_123094369 | 22.22 |
ENST00000455404.1
ENST00000218089.9 |
STAG2
|
stromal antigen 2 |
chr15_+_57210961 | 22.12 |
ENST00000557843.1
|
TCF12
|
transcription factor 12 |
chr16_+_85645007 | 22.07 |
ENST00000405402.2
|
GSE1
|
Gse1 coiled-coil protein |
chr2_+_219081817 | 21.88 |
ENST00000315717.5
ENST00000420104.1 ENST00000295685.10 |
ARPC2
|
actin related protein 2/3 complex, subunit 2, 34kDa |
chr1_+_94883931 | 21.87 |
ENST00000394233.2
ENST00000454898.2 ENST00000536817.1 |
ABCD3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
chr19_+_16186903 | 21.82 |
ENST00000588507.1
|
TPM4
|
tropomyosin 4 |
chr2_-_174828892 | 21.71 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
chr11_-_67169265 | 21.57 |
ENST00000358239.4
ENST00000376745.4 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
chr1_+_47799446 | 21.50 |
ENST00000371873.5
|
CMPK1
|
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic |
chr4_-_103748271 | 21.40 |
ENST00000343106.5
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr1_-_32403370 | 21.40 |
ENST00000534796.1
|
PTP4A2
|
protein tyrosine phosphatase type IVA, member 2 |
chrX_-_129244454 | 21.29 |
ENST00000308167.5
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
chr3_+_184079492 | 21.14 |
ENST00000456318.1
ENST00000412877.1 ENST00000438240.1 |
POLR2H
|
polymerase (RNA) II (DNA directed) polypeptide H |
chr2_-_136633940 | 21.02 |
ENST00000264156.2
|
MCM6
|
minichromosome maintenance complex component 6 |
chr8_-_67525473 | 20.94 |
ENST00000522677.3
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
chr4_-_83351294 | 20.55 |
ENST00000502762.1
|
HNRNPDL
|
heterogeneous nuclear ribonucleoprotein D-like |
chr20_+_35202909 | 20.49 |
ENST00000558530.1
ENST00000558028.1 ENST00000560025.1 |
TGIF2-C20orf24
TGIF2
|
TGIF2-C20orf24 readthrough TGFB-induced factor homeobox 2 |
chr6_+_135502466 | 20.48 |
ENST00000367814.4
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr3_-_127872625 | 20.25 |
ENST00000464873.1
|
RUVBL1
|
RuvB-like AAA ATPase 1 |
chr1_-_150208498 | 20.10 |
ENST00000314136.8
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
chr20_+_3776371 | 20.08 |
ENST00000245960.5
|
CDC25B
|
cell division cycle 25B |
chr12_+_69004619 | 20.06 |
ENST00000250559.9
ENST00000393436.5 ENST00000425247.2 ENST00000489473.2 ENST00000422358.2 ENST00000541167.1 ENST00000538283.1 ENST00000341355.5 ENST00000537460.1 ENST00000450214.2 ENST00000545270.1 ENST00000538980.1 ENST00000542018.1 ENST00000543393.1 |
RAP1B
|
RAP1B, member of RAS oncogene family |
chr22_-_36784035 | 20.02 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
chr11_-_76091986 | 19.85 |
ENST00000260045.3
|
PRKRIR
|
protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) |
chr6_+_135502408 | 19.52 |
ENST00000341911.5
ENST00000442647.2 ENST00000316528.8 |
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr20_+_3776936 | 19.50 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
chr14_+_23790690 | 19.40 |
ENST00000556821.1
|
PABPN1
|
poly(A) binding protein, nuclear 1 |
chr12_-_58146128 | 19.20 |
ENST00000551800.1
ENST00000549606.1 ENST00000257904.6 |
CDK4
|
cyclin-dependent kinase 4 |
chr20_+_47662805 | 19.17 |
ENST00000262982.2
ENST00000542325.1 |
CSE1L
|
CSE1 chromosome segregation 1-like (yeast) |
chr11_+_63706444 | 19.17 |
ENST00000377793.4
ENST00000456907.2 ENST00000539656.1 |
NAA40
|
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
chr1_+_94883991 | 19.16 |
ENST00000370214.4
|
ABCD3
|
ATP-binding cassette, sub-family D (ALD), member 3 |
chr17_-_42276574 | 19.12 |
ENST00000589805.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr12_-_57082060 | 19.09 |
ENST00000448157.2
ENST00000414274.3 ENST00000262033.6 ENST00000456859.2 |
PTGES3
|
prostaglandin E synthase 3 (cytosolic) |
chr14_-_23451467 | 19.07 |
ENST00000555074.1
ENST00000361265.4 |
RP11-298I3.5
AJUBA
|
RP11-298I3.5 ajuba LIM protein |
chr1_+_33116743 | 19.05 |
ENST00000414241.3
ENST00000373493.5 |
RBBP4
|
retinoblastoma binding protein 4 |
chr19_-_50432782 | 19.03 |
ENST00000413454.1
ENST00000596437.1 ENST00000341114.3 ENST00000595948.1 |
NUP62
IL4I1
|
nucleoporin 62kDa interleukin 4 induced 1 |
chr17_-_74733404 | 18.83 |
ENST00000508921.3
ENST00000583836.1 ENST00000358156.6 ENST00000392485.2 ENST00000359995.5 |
SRSF2
|
serine/arginine-rich splicing factor 2 |
chr17_+_36861735 | 18.61 |
ENST00000378137.5
ENST00000325718.7 |
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
chr1_-_150208412 | 18.61 |
ENST00000532744.1
ENST00000369114.5 ENST00000369115.2 ENST00000369116.4 |
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
chr15_+_57210818 | 18.54 |
ENST00000438423.2
ENST00000267811.5 ENST00000452095.2 ENST00000559609.1 ENST00000333725.5 |
TCF12
|
transcription factor 12 |
chr2_-_48132814 | 18.54 |
ENST00000316377.4
ENST00000378314.3 |
FBXO11
|
F-box protein 11 |
chr12_+_96252706 | 18.53 |
ENST00000266735.5
ENST00000553192.1 ENST00000552085.1 |
SNRPF
|
small nuclear ribonucleoprotein polypeptide F |
chrX_-_20284958 | 18.35 |
ENST00000379565.3
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
chr14_+_56046990 | 18.28 |
ENST00000438792.2
ENST00000395314.3 ENST00000395308.1 |
KTN1
|
kinectin 1 (kinesin receptor) |
chr5_+_133450365 | 18.26 |
ENST00000342854.5
ENST00000321603.6 ENST00000321584.4 ENST00000378564.1 ENST00000395029.1 |
TCF7
|
transcription factor 7 (T-cell specific, HMG-box) |
chr3_+_152017181 | 18.23 |
ENST00000498502.1
ENST00000324196.5 ENST00000545754.1 ENST00000357472.3 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr12_-_58146048 | 18.18 |
ENST00000547281.1
ENST00000546489.1 ENST00000552388.1 ENST00000540325.1 ENST00000312990.6 |
CDK4
|
cyclin-dependent kinase 4 |
chr6_+_20403997 | 18.14 |
ENST00000535432.1
|
E2F3
|
E2F transcription factor 3 |
chr3_+_152017360 | 18.14 |
ENST00000485910.1
ENST00000463374.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr17_+_38278826 | 17.98 |
ENST00000577454.1
ENST00000578648.1 ENST00000579565.1 |
MSL1
|
male-specific lethal 1 homolog (Drosophila) |
chr20_+_31407692 | 17.96 |
ENST00000375571.5
|
MAPRE1
|
microtubule-associated protein, RP/EB family, member 1 |
chr7_+_98972298 | 17.93 |
ENST00000252725.5
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
chr5_+_61602055 | 17.68 |
ENST00000381103.2
|
KIF2A
|
kinesin heavy chain member 2A |
chr7_+_150756657 | 17.56 |
ENST00000413384.2
|
SLC4A2
|
solute carrier family 4 (anion exchanger), member 2 |
chr2_-_174830430 | 17.54 |
ENST00000310015.6
ENST00000455789.2 |
SP3
|
Sp3 transcription factor |
chr1_+_62901968 | 17.46 |
ENST00000452143.1
ENST00000442679.1 ENST00000371146.1 |
USP1
|
ubiquitin specific peptidase 1 |
chr12_+_98909351 | 17.27 |
ENST00000343315.5
ENST00000266732.4 ENST00000393053.2 |
TMPO
|
thymopoietin |
chr10_-_120840309 | 17.22 |
ENST00000369144.3
|
EIF3A
|
eukaryotic translation initiation factor 3, subunit A |
chr15_-_85259294 | 17.20 |
ENST00000558217.1
ENST00000558196.1 ENST00000558134.1 |
SEC11A
|
SEC11 homolog A (S. cerevisiae) |
chr14_+_50359773 | 17.16 |
ENST00000298316.5
|
ARF6
|
ADP-ribosylation factor 6 |
chr6_-_18265050 | 17.15 |
ENST00000397239.3
|
DEK
|
DEK oncogene |
chr4_+_57302297 | 17.03 |
ENST00000399688.3
ENST00000512576.1 |
PAICS
|
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
chr1_-_67896009 | 17.02 |
ENST00000370990.5
|
SERBP1
|
SERPINE1 mRNA binding protein 1 |
chr3_+_9439400 | 17.01 |
ENST00000450326.1
ENST00000402198.1 ENST00000402466.1 |
SETD5
|
SET domain containing 5 |
chr6_-_41909466 | 17.00 |
ENST00000414200.2
|
CCND3
|
cyclin D3 |
chr2_-_38978492 | 16.95 |
ENST00000409276.1
ENST00000446327.2 ENST00000313117.6 |
SRSF7
|
serine/arginine-rich splicing factor 7 |
chr1_-_155904187 | 16.91 |
ENST00000368321.3
ENST00000368320.3 |
KIAA0907
|
KIAA0907 |
chr13_+_114238997 | 16.79 |
ENST00000538138.1
ENST00000375370.5 |
TFDP1
|
transcription factor Dp-1 |
chr6_-_41909561 | 16.76 |
ENST00000372991.4
|
CCND3
|
cyclin D3 |
chr19_+_3572925 | 16.75 |
ENST00000333651.6
ENST00000417382.1 ENST00000453933.1 ENST00000262949.7 |
HMG20B
|
high mobility group 20B |
chr2_+_232573222 | 16.64 |
ENST00000341369.7
ENST00000409683.1 |
PTMA
|
prothymosin, alpha |
chr11_-_67169253 | 16.64 |
ENST00000527663.1
ENST00000312989.7 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
chr18_+_3449821 | 16.64 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
chr7_-_132766818 | 16.51 |
ENST00000262570.5
|
CHCHD3
|
coiled-coil-helix-coiled-coil-helix domain containing 3 |
chr9_-_15510989 | 16.51 |
ENST00000380715.1
ENST00000380716.4 ENST00000380738.4 ENST00000380733.4 |
PSIP1
|
PC4 and SFRS1 interacting protein 1 |
chr19_-_55919087 | 16.48 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
chr2_+_232573208 | 16.38 |
ENST00000409115.3
|
PTMA
|
prothymosin, alpha |
chr1_+_113161778 | 16.31 |
ENST00000263168.3
|
CAPZA1
|
capping protein (actin filament) muscle Z-line, alpha 1 |
chr8_-_17104356 | 16.27 |
ENST00000361272.4
ENST00000523917.1 |
CNOT7
|
CCR4-NOT transcription complex, subunit 7 |
chr4_-_83295103 | 16.27 |
ENST00000313899.7
ENST00000352301.4 ENST00000509107.1 ENST00000353341.4 ENST00000541060.1 |
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) |
chr17_+_7210898 | 16.26 |
ENST00000572815.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr1_-_67896095 | 16.24 |
ENST00000370994.4
|
SERBP1
|
SERPINE1 mRNA binding protein 1 |
chr6_+_37137939 | 16.22 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
chr14_+_56046914 | 16.15 |
ENST00000413890.2
ENST00000395309.3 ENST00000554567.1 ENST00000555498.1 |
KTN1
|
kinectin 1 (kinesin receptor) |
chr3_-_185655795 | 15.98 |
ENST00000342294.4
ENST00000382191.4 ENST00000453386.2 |
TRA2B
|
transformer 2 beta homolog (Drosophila) |
chr1_-_150208363 | 15.90 |
ENST00000436748.2
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
chr5_+_133861790 | 15.89 |
ENST00000395003.1
|
PHF15
|
jade family PHD finger 2 |
chr5_+_65222299 | 15.75 |
ENST00000284037.5
|
ERBB2IP
|
erbb2 interacting protein |
chr9_+_33025209 | 15.68 |
ENST00000330899.4
ENST00000544625.1 |
DNAJA1
|
DnaJ (Hsp40) homolog, subfamily A, member 1 |
chr15_-_85259330 | 15.60 |
ENST00000560266.1
|
SEC11A
|
SEC11 homolog A (S. cerevisiae) |
chr7_-_132766800 | 15.59 |
ENST00000542753.1
ENST00000448878.1 |
CHCHD3
|
coiled-coil-helix-coiled-coil-helix domain containing 3 |
chr1_-_35658736 | 15.52 |
ENST00000357214.5
|
SFPQ
|
splicing factor proline/glutamine-rich |
chr22_+_41347363 | 15.51 |
ENST00000216225.8
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase |
chr2_-_27632390 | 15.43 |
ENST00000350803.4
ENST00000344034.4 |
PPM1G
|
protein phosphatase, Mg2+/Mn2+ dependent, 1G |
chr18_-_51751132 | 15.23 |
ENST00000256429.3
|
MBD2
|
methyl-CpG binding domain protein 2 |
chr14_+_64970662 | 15.09 |
ENST00000556965.1
ENST00000554015.1 |
ZBTB1
|
zinc finger and BTB domain containing 1 |
chr18_+_3449695 | 15.03 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr1_-_67896069 | 15.02 |
ENST00000370995.2
ENST00000361219.6 |
SERBP1
|
SERPINE1 mRNA binding protein 1 |
chr18_+_29672573 | 14.99 |
ENST00000578107.1
ENST00000257190.5 ENST00000580499.1 |
RNF138
|
ring finger protein 138, E3 ubiquitin protein ligase |
chrX_+_123094672 | 14.92 |
ENST00000354548.5
ENST00000458700.1 |
STAG2
|
stromal antigen 2 |
chr1_+_154947126 | 14.89 |
ENST00000368439.1
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B |
chr15_-_85259384 | 14.78 |
ENST00000455959.3
|
SEC11A
|
SEC11 homolog A (S. cerevisiae) |
chr20_-_49547910 | 14.77 |
ENST00000396032.3
|
ADNP
|
activity-dependent neuroprotector homeobox |
chr16_-_28222797 | 14.68 |
ENST00000569951.1
ENST00000565698.1 |
XPO6
|
exportin 6 |
chr7_+_116502605 | 14.61 |
ENST00000458284.2
ENST00000490693.1 |
CAPZA2
|
capping protein (actin filament) muscle Z-line, alpha 2 |
chr2_+_86668464 | 14.57 |
ENST00000409064.1
|
KDM3A
|
lysine (K)-specific demethylase 3A |
chr17_-_46178741 | 14.51 |
ENST00000581003.1
ENST00000225603.4 |
CBX1
|
chromobox homolog 1 |
chr5_+_65440032 | 14.50 |
ENST00000334121.6
|
SREK1
|
splicing regulatory glutamine/lysine-rich protein 1 |
chr3_+_9439579 | 14.49 |
ENST00000406341.1
|
SETD5
|
SET domain containing 5 |
chr2_-_153574480 | 14.35 |
ENST00000410080.1
|
PRPF40A
|
PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) |
chr1_-_156721502 | 14.31 |
ENST00000357325.5
|
HDGF
|
hepatoma-derived growth factor |
chr20_-_5100591 | 14.28 |
ENST00000379143.5
|
PCNA
|
proliferating cell nuclear antigen |
chr3_+_133292759 | 14.25 |
ENST00000431519.2
|
CDV3
|
CDV3 homolog (mouse) |
chr7_+_98972345 | 14.20 |
ENST00000418347.2
ENST00000429246.1 ENST00000417330.1 ENST00000431816.1 ENST00000427217.1 ENST00000458033.1 ENST00000451682.1 |
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
chr6_-_41909191 | 14.16 |
ENST00000512426.1
ENST00000372987.4 |
CCND3
|
cyclin D3 |
chr2_-_48132924 | 14.13 |
ENST00000403359.3
|
FBXO11
|
F-box protein 11 |
chr15_+_75074410 | 14.08 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
chr17_-_46178527 | 14.01 |
ENST00000393408.3
|
CBX1
|
chromobox homolog 1 |
chr11_+_85956182 | 14.01 |
ENST00000327320.4
ENST00000351625.6 ENST00000534595.1 |
EED
|
embryonic ectoderm development |
chr17_-_29151794 | 13.97 |
ENST00000324238.6
|
CRLF3
|
cytokine receptor-like factor 3 |
chr6_+_24775153 | 13.93 |
ENST00000356509.3
ENST00000230056.3 |
GMNN
|
geminin, DNA replication inhibitor |
chr4_-_100871506 | 13.92 |
ENST00000296417.5
|
H2AFZ
|
H2A histone family, member Z |
chr6_+_30689401 | 13.88 |
ENST00000396389.1
ENST00000396384.1 |
TUBB
|
tubulin, beta class I |
chr1_+_33116765 | 13.81 |
ENST00000544435.1
ENST00000373485.1 ENST00000458695.2 ENST00000490500.1 ENST00000445722.2 |
RBBP4
|
retinoblastoma binding protein 4 |
chrX_-_109561294 | 13.61 |
ENST00000372059.2
ENST00000262844.5 |
AMMECR1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr1_-_245027766 | 13.56 |
ENST00000283179.9
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) |
chr7_-_138794081 | 13.55 |
ENST00000464606.1
|
ZC3HAV1
|
zinc finger CCCH-type, antiviral 1 |
chr20_+_306221 | 13.45 |
ENST00000342665.2
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr14_+_24605361 | 13.35 |
ENST00000206451.6
ENST00000559123.1 |
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr5_+_6714718 | 13.33 |
ENST00000230859.6
ENST00000515721.1 |
PAPD7
|
PAP associated domain containing 7 |
chr9_+_110045537 | 13.29 |
ENST00000358015.3
|
RAD23B
|
RAD23 homolog B (S. cerevisiae) |
chr2_+_136289030 | 13.21 |
ENST00000409478.1
ENST00000264160.4 ENST00000329971.3 ENST00000438014.1 |
R3HDM1
|
R3H domain containing 1 |
chr17_-_62658186 | 13.19 |
ENST00000262435.9
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2 |
chr19_-_8070474 | 13.13 |
ENST00000407627.2
ENST00000593807.1 |
ELAVL1
|
ELAV like RNA binding protein 1 |
chr15_-_69113218 | 13.13 |
ENST00000560303.1
ENST00000465139.2 |
ANP32A
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
chr10_+_70661014 | 13.03 |
ENST00000373585.3
|
DDX50
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
32.5 | 227.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
23.2 | 116.0 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
18.9 | 132.0 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
16.1 | 80.6 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
15.8 | 47.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
15.8 | 63.2 | GO:0002840 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
15.6 | 46.7 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
12.1 | 36.3 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
12.1 | 36.2 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
11.1 | 33.3 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
9.6 | 38.2 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
9.2 | 36.8 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
8.8 | 8.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
8.5 | 51.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
8.4 | 84.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
8.4 | 67.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
7.9 | 31.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
7.8 | 23.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
7.6 | 30.2 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
7.4 | 73.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
7.4 | 22.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
6.7 | 20.1 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
6.7 | 20.0 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
6.7 | 46.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
6.5 | 39.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
6.3 | 31.4 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
6.2 | 30.8 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
6.1 | 24.3 | GO:1901858 | regulation of mitochondrial DNA replication(GO:0090296) regulation of mitochondrial DNA metabolic process(GO:1901858) |
6.0 | 12.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
6.0 | 60.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
6.0 | 18.0 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
5.8 | 29.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
5.7 | 17.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) translation reinitiation(GO:0002188) |
5.6 | 39.2 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
5.6 | 22.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
5.5 | 16.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
5.5 | 16.5 | GO:0030474 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
5.4 | 16.3 | GO:1901355 | response to rapamycin(GO:1901355) |
5.2 | 20.9 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
5.2 | 15.6 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
5.0 | 25.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
5.0 | 59.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
4.9 | 49.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
4.8 | 24.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
4.8 | 9.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
4.8 | 14.3 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
4.7 | 47.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
4.5 | 31.5 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
4.3 | 56.1 | GO:0006265 | DNA topological change(GO:0006265) |
4.3 | 12.8 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
4.2 | 58.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
4.2 | 4.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
4.1 | 41.4 | GO:0007144 | female meiosis I(GO:0007144) |
4.1 | 20.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
4.1 | 16.4 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
4.1 | 12.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
4.0 | 12.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
4.0 | 12.0 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
4.0 | 11.9 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
4.0 | 11.9 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
3.9 | 11.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
3.9 | 19.5 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
3.8 | 26.8 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
3.8 | 11.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
3.8 | 11.5 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
3.8 | 15.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.7 | 15.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
3.7 | 11.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
3.6 | 25.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
3.6 | 10.9 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
3.6 | 78.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
3.5 | 21.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
3.5 | 31.5 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
3.5 | 164.0 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
3.4 | 13.7 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
3.4 | 23.9 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
3.4 | 23.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
3.3 | 16.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
3.3 | 16.6 | GO:0015862 | uridine transport(GO:0015862) |
3.3 | 9.9 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
3.3 | 16.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
3.3 | 6.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
3.2 | 12.9 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
3.2 | 32.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
3.2 | 6.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
3.2 | 12.6 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
3.1 | 9.3 | GO:1905031 | regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905031) |
3.1 | 15.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
3.1 | 21.7 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
3.1 | 15.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
3.1 | 18.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
3.1 | 12.3 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
3.0 | 48.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
3.0 | 9.0 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
3.0 | 18.0 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
3.0 | 3.0 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
3.0 | 14.8 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
2.9 | 5.9 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.9 | 20.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.9 | 38.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
2.9 | 23.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
2.9 | 8.6 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
2.9 | 94.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
2.8 | 31.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.8 | 64.8 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
2.8 | 58.4 | GO:0006465 | signal peptide processing(GO:0006465) |
2.8 | 2.8 | GO:0032768 | regulation of monooxygenase activity(GO:0032768) |
2.7 | 8.2 | GO:0045658 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
2.7 | 8.2 | GO:0052251 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
2.7 | 10.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.7 | 13.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
2.7 | 5.3 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
2.6 | 21.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
2.6 | 7.8 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
2.6 | 85.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
2.5 | 10.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
2.5 | 15.1 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
2.5 | 15.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
2.5 | 32.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
2.5 | 20.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
2.5 | 12.4 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
2.4 | 29.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
2.4 | 14.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
2.4 | 9.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
2.4 | 7.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
2.4 | 26.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
2.4 | 7.1 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
2.3 | 7.0 | GO:1903181 | positive regulation of Wnt protein secretion(GO:0061357) regulation of late endosome to lysosome transport(GO:1902822) regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) negative regulation of vacuolar transport(GO:1903336) negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
2.3 | 25.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
2.3 | 20.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
2.3 | 6.8 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
2.2 | 13.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
2.2 | 8.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.2 | 13.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
2.2 | 10.9 | GO:0021553 | olfactory nerve development(GO:0021553) |
2.2 | 6.5 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
2.2 | 8.6 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
2.2 | 17.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
2.1 | 12.9 | GO:0007296 | vitellogenesis(GO:0007296) |
2.1 | 15.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
2.1 | 85.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
2.1 | 32.0 | GO:0051639 | actin filament network formation(GO:0051639) |
2.1 | 10.5 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
2.1 | 176.9 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
2.1 | 20.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
2.1 | 24.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
2.1 | 14.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
2.0 | 6.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.0 | 14.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
2.0 | 35.9 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
2.0 | 43.5 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
2.0 | 5.9 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
2.0 | 7.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.0 | 3.9 | GO:0060374 | mast cell differentiation(GO:0060374) |
2.0 | 7.9 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
2.0 | 21.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.9 | 7.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.9 | 19.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
1.9 | 9.5 | GO:0060022 | hard palate development(GO:0060022) |
1.9 | 7.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.9 | 5.7 | GO:0032679 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) protection from natural killer cell mediated cytotoxicity(GO:0042270) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.9 | 5.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
1.8 | 5.5 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
1.8 | 3.6 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
1.8 | 10.8 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
1.8 | 9.0 | GO:0006740 | NADPH regeneration(GO:0006740) |
1.8 | 23.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
1.8 | 5.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
1.7 | 24.4 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
1.7 | 1.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.7 | 5.1 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
1.7 | 6.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.7 | 5.1 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
1.7 | 5.1 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
1.7 | 8.4 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
1.7 | 23.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.7 | 5.0 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
1.6 | 66.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
1.6 | 16.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.6 | 1.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
1.6 | 7.9 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
1.6 | 11.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.6 | 7.8 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
1.6 | 9.3 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
1.5 | 9.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
1.5 | 8.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.5 | 50.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.5 | 10.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.5 | 32.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.5 | 5.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.5 | 7.3 | GO:0030047 | actin modification(GO:0030047) |
1.4 | 5.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.4 | 59.0 | GO:0043486 | histone exchange(GO:0043486) |
1.4 | 10.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
1.4 | 15.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.4 | 36.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.4 | 14.1 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
1.4 | 7.0 | GO:1902741 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
1.4 | 8.3 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
1.4 | 5.5 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
1.4 | 24.7 | GO:1903540 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
1.4 | 12.3 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
1.4 | 4.1 | GO:1902309 | regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.4 | 2.7 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
1.3 | 18.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.3 | 22.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
1.3 | 23.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.3 | 2.6 | GO:0061511 | centriole elongation(GO:0061511) |
1.3 | 10.2 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.3 | 16.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.3 | 6.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
1.3 | 10.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.3 | 3.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.3 | 11.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
1.3 | 17.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
1.2 | 6.2 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.2 | 14.5 | GO:0010225 | response to UV-C(GO:0010225) |
1.2 | 6.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.2 | 22.9 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
1.2 | 25.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.2 | 14.4 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.2 | 3.6 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.2 | 7.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
1.2 | 2.4 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
1.2 | 16.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.1 | 22.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.1 | 8.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.1 | 9.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
1.1 | 11.0 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
1.1 | 4.4 | GO:1902748 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
1.1 | 5.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.1 | 21.6 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
1.1 | 11.8 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.1 | 2.1 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
1.1 | 4.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.1 | 6.3 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
1.1 | 19.0 | GO:0051014 | actin filament severing(GO:0051014) |
1.1 | 4.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.0 | 15.6 | GO:0033197 | response to vitamin E(GO:0033197) |
1.0 | 4.1 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
1.0 | 5.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.0 | 5.0 | GO:0050957 | equilibrioception(GO:0050957) |
1.0 | 3.0 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.0 | 3.0 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
1.0 | 6.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.0 | 6.0 | GO:2000510 | peptide antigen assembly with MHC protein complex(GO:0002501) positive regulation of dendritic cell chemotaxis(GO:2000510) |
1.0 | 7.0 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
1.0 | 6.9 | GO:0006116 | NADH oxidation(GO:0006116) |
1.0 | 11.8 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
1.0 | 63.2 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
1.0 | 1.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.0 | 9.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.9 | 2.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.9 | 2.8 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.9 | 10.3 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.9 | 2.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.9 | 2.8 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.9 | 15.8 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.9 | 6.3 | GO:0030220 | platelet formation(GO:0030220) |
0.9 | 2.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.9 | 6.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.9 | 2.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.9 | 4.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 3.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.9 | 3.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 19.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.8 | 1.7 | GO:1902903 | regulation of fibril organization(GO:1902903) |
0.8 | 4.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.8 | 4.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.8 | 8.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.8 | 22.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.8 | 4.0 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.8 | 11.2 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.8 | 8.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.8 | 28.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.8 | 10.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.8 | 2.3 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.7 | 0.7 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.7 | 8.1 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.7 | 14.6 | GO:0006342 | chromatin silencing(GO:0006342) |
0.7 | 10.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.7 | 10.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.7 | 2.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.7 | 2.2 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.7 | 4.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.7 | 2.8 | GO:0030242 | pexophagy(GO:0030242) |
0.7 | 5.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.7 | 2.8 | GO:0090670 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) |
0.7 | 19.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.7 | 8.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.7 | 7.5 | GO:0044598 | polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.7 | 0.7 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.7 | 4.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.7 | 3.3 | GO:0071462 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
0.7 | 10.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.7 | 2.0 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.7 | 6.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.6 | 4.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.6 | 1.9 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.6 | 1.9 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.6 | 2.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.6 | 5.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.6 | 7.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.6 | 3.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 2.5 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.6 | 2.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.6 | 4.2 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.6 | 3.0 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.6 | 2.4 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
0.6 | 6.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.6 | 3.6 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.6 | 3.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.6 | 1.2 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.6 | 3.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.6 | 10.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.6 | 0.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.6 | 2.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.6 | 3.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.6 | 9.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.6 | 12.7 | GO:0002063 | chondrocyte development(GO:0002063) |
0.6 | 34.3 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.6 | 2.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.6 | 10.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 21.4 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.6 | 5.6 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.6 | 3.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.6 | 3.9 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.6 | 1.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.6 | 10.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.5 | 2.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.5 | 3.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.5 | 6.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.5 | 2.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.5 | 9.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.5 | 19.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.5 | 8.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 2.6 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.5 | 2.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 1.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.5 | 6.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.5 | 3.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 10.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.5 | 1.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.5 | 13.9 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.5 | 45.8 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.5 | 2.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 0.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 39.3 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.5 | 34.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.5 | 5.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.5 | 4.2 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.5 | 5.1 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.5 | 6.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 5.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.5 | 5.9 | GO:0042026 | protein refolding(GO:0042026) |
0.4 | 4.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.4 | 1.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 4.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.4 | 7.1 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.4 | 3.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.4 | 7.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.4 | 3.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 3.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.4 | 17.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.4 | 5.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.4 | 5.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 6.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.4 | 29.0 | GO:0051225 | spindle assembly(GO:0051225) |
0.4 | 1.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.4 | 1.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.4 | 15.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.4 | 2.0 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.4 | 2.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 2.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 12.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.4 | 1.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.4 | 1.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.4 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.4 | 4.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 16.2 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.4 | 2.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 9.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.4 | 3.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.4 | 9.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 2.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 1.8 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.4 | 1.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 2.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 3.5 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.3 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 1.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 1.4 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.3 | 5.7 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.3 | 1.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 11.7 | GO:0006414 | translational elongation(GO:0006414) |
0.3 | 1.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.3 | 1.0 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 17.5 | GO:0016575 | histone deacetylation(GO:0016575) |
0.3 | 0.9 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.3 | 1.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 0.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 24.3 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.3 | 2.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 3.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.3 | 2.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 2.7 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 3.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 2.3 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.3 | 2.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 2.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 2.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 2.3 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 9.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 2.5 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.3 | 7.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.3 | 7.2 | GO:0006412 | translation(GO:0006412) |
0.3 | 6.3 | GO:0032392 | DNA geometric change(GO:0032392) |
0.3 | 6.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 14.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 1.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.5 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.3 | 3.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 0.5 | GO:0035283 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 1.2 | GO:0016458 | gene silencing(GO:0016458) |
0.2 | 4.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.9 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.2 | 3.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 2.5 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.2 | 24.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 8.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.2 | 1.6 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.2 | 6.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 1.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 2.4 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 1.5 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 1.3 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 7.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 21.4 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.2 | 12.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 6.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 20.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 7.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 5.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 2.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 4.6 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 1.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 5.0 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 0.8 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) regulation of histone H3-K9 acetylation(GO:2000615) |
0.2 | 9.2 | GO:0031100 | organ regeneration(GO:0031100) |
0.2 | 1.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.2 | 1.5 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 4.9 | GO:0007140 | male meiosis(GO:0007140) |
0.2 | 1.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.2 | 10.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 8.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 1.7 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.2 | 1.4 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 1.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 2.5 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.2 | 4.3 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.2 | 1.3 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.2 | 6.2 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.2 | 0.5 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.5 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.2 | 1.5 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.2 | 0.6 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.7 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 1.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 1.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.1 | 0.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 1.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 5.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 15.3 | GO:0070268 | cornification(GO:0070268) |
0.1 | 3.7 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 4.9 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.1 | 1.0 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 5.4 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 1.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.4 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.1 | 2.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 2.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 1.2 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 1.8 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 4.3 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 1.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 4.7 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.1 | 1.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 5.8 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.1 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 4.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 2.5 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.2 | GO:0060459 | subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
0.1 | 0.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.9 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 4.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.3 | GO:0071389 | cellular response to corticosterone stimulus(GO:0071386) cellular response to mineralocorticoid stimulus(GO:0071389) |
0.1 | 2.2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 2.4 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.1 | 0.4 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 1.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 2.4 | GO:1903391 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of adherens junction organization(GO:1903391) |
0.0 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.1 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.0 | 0.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 1.1 | GO:0030810 | positive regulation of nucleotide biosynthetic process(GO:0030810) positive regulation of purine nucleotide biosynthetic process(GO:1900373) |
0.0 | 1.7 | GO:0017148 | negative regulation of translation(GO:0017148) |
0.0 | 0.9 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.1 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.0 | 0.9 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0033260 | nuclear DNA replication(GO:0033260) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.3 | 194.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
8.4 | 33.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
8.3 | 58.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
7.9 | 23.8 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
7.8 | 77.7 | GO:0001739 | sex chromatin(GO:0001739) |
7.7 | 23.2 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
7.3 | 21.9 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
7.1 | 28.6 | GO:0001740 | Barr body(GO:0001740) |
6.7 | 20.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
6.4 | 154.5 | GO:0071564 | npBAF complex(GO:0071564) |
6.4 | 76.8 | GO:0090544 | BAF-type complex(GO:0090544) |
6.2 | 24.9 | GO:0032301 | MutSalpha complex(GO:0032301) |
6.2 | 6.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
5.9 | 41.2 | GO:0031415 | NatA complex(GO:0031415) |
5.8 | 40.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
5.7 | 22.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
5.5 | 33.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
5.5 | 16.5 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
5.4 | 59.1 | GO:0005642 | annulate lamellae(GO:0005642) |
5.3 | 26.3 | GO:0097422 | tubular endosome(GO:0097422) |
5.2 | 93.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
5.2 | 15.5 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
5.1 | 76.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
5.1 | 51.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
5.1 | 20.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
5.0 | 25.0 | GO:0001940 | male pronucleus(GO:0001940) |
5.0 | 19.8 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
4.8 | 62.1 | GO:0042555 | MCM complex(GO:0042555) |
4.7 | 99.0 | GO:0000812 | Swr1 complex(GO:0000812) |
4.6 | 46.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
4.6 | 32.1 | GO:0061617 | MICOS complex(GO:0061617) |
4.3 | 25.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
4.0 | 19.8 | GO:0035061 | interchromatin granule(GO:0035061) |
3.9 | 23.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
3.6 | 61.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
3.6 | 10.7 | GO:0030689 | Noc complex(GO:0030689) |
3.4 | 13.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
3.4 | 23.5 | GO:0090543 | Flemming body(GO:0090543) |
3.2 | 9.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
3.1 | 25.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
3.1 | 87.5 | GO:0031143 | pseudopodium(GO:0031143) |
3.1 | 9.3 | GO:0031523 | Myb complex(GO:0031523) |
3.1 | 9.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
3.0 | 18.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.7 | 13.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.7 | 19.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
2.7 | 8.0 | GO:0043291 | RAVE complex(GO:0043291) |
2.6 | 39.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.6 | 7.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
2.6 | 38.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
2.6 | 12.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
2.5 | 7.4 | GO:0071159 | NF-kappaB complex(GO:0071159) |
2.5 | 4.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.4 | 45.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
2.4 | 23.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
2.4 | 7.1 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
2.4 | 80.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
2.3 | 7.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
2.2 | 11.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
2.2 | 24.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
2.1 | 289.0 | GO:0016605 | PML body(GO:0016605) |
2.1 | 8.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.1 | 21.2 | GO:0000796 | condensin complex(GO:0000796) |
2.1 | 14.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
2.1 | 14.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
2.0 | 21.9 | GO:0005688 | U6 snRNP(GO:0005688) |
1.9 | 17.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
1.9 | 15.5 | GO:0042382 | paraspeckles(GO:0042382) |
1.9 | 17.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.9 | 32.4 | GO:0032059 | bleb(GO:0032059) |
1.9 | 41.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.8 | 9.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.8 | 18.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.8 | 8.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.8 | 14.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
1.8 | 31.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.7 | 6.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.7 | 34.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.7 | 11.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.7 | 5.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
1.7 | 47.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.6 | 75.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.6 | 25.6 | GO:0035861 | site of double-strand break(GO:0035861) |
1.5 | 15.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.5 | 40.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.5 | 9.2 | GO:0032039 | integrator complex(GO:0032039) |
1.5 | 24.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
1.5 | 7.5 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
1.5 | 10.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.5 | 13.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.5 | 6.0 | GO:0000811 | GINS complex(GO:0000811) |
1.4 | 18.7 | GO:0097227 | sperm annulus(GO:0097227) |
1.4 | 156.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.4 | 8.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.4 | 7.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
1.4 | 7.0 | GO:0016589 | NURF complex(GO:0016589) |
1.4 | 9.8 | GO:0034709 | methylosome(GO:0034709) |
1.4 | 76.7 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
1.4 | 9.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.4 | 6.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.3 | 18.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.3 | 32.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.3 | 17.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.3 | 19.0 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
1.3 | 13.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.3 | 6.3 | GO:0032021 | NELF complex(GO:0032021) |
1.2 | 6.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.2 | 6.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.2 | 35.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.1 | 14.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.1 | 3.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.1 | 14.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 5.5 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
1.1 | 75.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.1 | 5.5 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
1.1 | 7.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.1 | 12.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.1 | 4.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.0 | 44.7 | GO:1990391 | DNA repair complex(GO:1990391) |
1.0 | 5.1 | GO:0032449 | CBM complex(GO:0032449) |
1.0 | 10.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
1.0 | 7.0 | GO:0072487 | MSL complex(GO:0072487) |
1.0 | 3.0 | GO:0031261 | nuclear pre-replicative complex(GO:0005656) DNA replication preinitiation complex(GO:0031261) pre-replicative complex(GO:0036387) |
1.0 | 4.8 | GO:0001652 | granular component(GO:0001652) |
0.9 | 5.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.9 | 5.6 | GO:0010369 | chromocenter(GO:0010369) |
0.9 | 28.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.9 | 2.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.9 | 5.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.9 | 1.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.9 | 4.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.8 | 46.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.8 | 56.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.8 | 3.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.8 | 6.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.8 | 3.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.8 | 77.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.7 | 6.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.7 | 57.8 | GO:0005811 | lipid particle(GO:0005811) |
0.7 | 103.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.7 | 15.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.7 | 7.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.7 | 17.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.7 | 2.7 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.6 | 5.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 2.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 17.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.6 | 5.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.6 | 2.6 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.6 | 5.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 6.2 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 3.4 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
0.5 | 51.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.5 | 7.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.5 | 3.6 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.5 | 4.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.5 | 4.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.5 | 1.5 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.5 | 3.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 3.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.5 | 9.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 13.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 6.9 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.5 | 5.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 154.2 | GO:0000785 | chromatin(GO:0000785) |
0.5 | 11.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.5 | 3.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 3.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 93.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 1.7 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.4 | 21.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 3.8 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.4 | 11.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 20.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 2.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.4 | 1.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 93.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.4 | 2.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.4 | 2.5 | GO:0070187 | telosome(GO:0070187) |
0.3 | 19.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 2.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 4.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 1.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 11.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.3 | 3.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 3.0 | GO:0005814 | centriole(GO:0005814) |
0.3 | 11.3 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 4.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 6.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 2.0 | GO:0005938 | cell cortex(GO:0005938) |
0.3 | 3.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 7.0 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 4.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 9.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 21.9 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 29.7 | GO:0030496 | midbody(GO:0030496) |
0.2 | 30.8 | GO:0005635 | nuclear envelope(GO:0005635) |
0.2 | 8.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 1.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 19.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 25.8 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.2 | 0.8 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 6.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 4.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 1.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 9.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 2.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 11.6 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 11.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 3.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 5.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 10.2 | GO:0005819 | spindle(GO:0005819) |
0.1 | 3.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.6 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 3.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 7.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.1 | 3.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 9.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 1.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 2.4 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 9.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 1.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 3.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.2 | GO:0031213 | RSF complex(GO:0031213) |
0.1 | 4.3 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 10.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 7.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 1.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.2 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.0 | 5.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.0 | 52.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
12.1 | 36.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
11.6 | 46.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
11.2 | 145.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
10.5 | 63.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
9.8 | 117.7 | GO:0031386 | protein tag(GO:0031386) |
9.6 | 86.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
8.1 | 32.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
7.9 | 23.8 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
6.7 | 80.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
6.2 | 24.9 | GO:0032143 | single thymine insertion binding(GO:0032143) |
5.7 | 22.8 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
5.5 | 60.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
5.1 | 5.1 | GO:0032427 | GBD domain binding(GO:0032427) |
4.9 | 14.8 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
4.8 | 14.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
4.6 | 60.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
4.6 | 139.1 | GO:0008143 | poly(A) binding(GO:0008143) |
4.5 | 31.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
4.4 | 26.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
4.3 | 12.9 | GO:0034452 | dynactin binding(GO:0034452) |
4.2 | 129.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
4.1 | 16.4 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
4.0 | 12.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
4.0 | 12.0 | GO:0004802 | transketolase activity(GO:0004802) |
4.0 | 12.0 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
3.8 | 26.8 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
3.8 | 19.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
3.7 | 55.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
3.7 | 14.6 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
3.7 | 21.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
3.6 | 127.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
3.6 | 10.9 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
3.6 | 25.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
3.6 | 21.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
3.5 | 21.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
3.5 | 24.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
3.5 | 24.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
3.4 | 37.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
3.4 | 13.5 | GO:0043398 | HLH domain binding(GO:0043398) |
3.4 | 23.5 | GO:0050733 | RS domain binding(GO:0050733) |
3.3 | 40.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
3.3 | 10.0 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
3.3 | 23.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
3.3 | 16.5 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
3.3 | 9.9 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
3.3 | 29.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
3.3 | 42.5 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
3.2 | 139.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
3.2 | 129.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
3.1 | 9.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
3.0 | 11.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
2.8 | 73.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
2.8 | 11.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
2.7 | 8.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.7 | 24.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
2.6 | 15.7 | GO:0030957 | Tat protein binding(GO:0030957) |
2.6 | 114.7 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
2.6 | 7.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
2.5 | 15.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
2.5 | 17.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
2.5 | 27.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
2.5 | 17.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
2.4 | 14.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
2.4 | 43.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
2.4 | 42.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.4 | 37.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
2.3 | 9.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
2.3 | 16.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.3 | 6.9 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
2.3 | 9.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.3 | 13.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
2.2 | 6.7 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
2.2 | 11.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
2.2 | 6.7 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
2.2 | 15.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
2.2 | 34.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
2.2 | 10.8 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
2.1 | 19.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.1 | 6.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
2.1 | 43.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.1 | 8.3 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
2.1 | 43.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
2.0 | 10.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.0 | 7.9 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
2.0 | 21.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
2.0 | 5.9 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
2.0 | 11.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.9 | 5.6 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
1.8 | 23.2 | GO:0038132 | neuregulin binding(GO:0038132) |
1.8 | 3.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.8 | 5.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
1.7 | 7.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.7 | 5.1 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
1.7 | 5.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.6 | 6.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
1.6 | 4.9 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
1.6 | 87.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
1.6 | 21.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.6 | 7.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.6 | 24.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.6 | 10.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.6 | 12.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.5 | 4.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.5 | 7.6 | GO:0004359 | glutaminase activity(GO:0004359) |
1.5 | 183.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.5 | 7.6 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
1.5 | 32.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.5 | 4.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.5 | 5.9 | GO:0038025 | reelin receptor activity(GO:0038025) |
1.5 | 4.4 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.5 | 46.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.4 | 41.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.4 | 39.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.4 | 12.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.4 | 9.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.4 | 16.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.4 | 9.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
1.3 | 75.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
1.3 | 22.2 | GO:0005522 | profilin binding(GO:0005522) |
1.3 | 15.6 | GO:0000339 | RNA cap binding(GO:0000339) |
1.3 | 5.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.3 | 7.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.3 | 10.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.2 | 46.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
1.2 | 7.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.2 | 8.7 | GO:0046790 | virion binding(GO:0046790) |
1.2 | 16.1 | GO:0031996 | thioesterase binding(GO:0031996) |
1.2 | 8.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.2 | 15.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.2 | 83.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
1.2 | 6.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.2 | 58.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.2 | 10.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
1.2 | 7.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.2 | 45.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.1 | 3.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.1 | 17.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
1.1 | 3.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
1.1 | 13.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.1 | 6.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
1.1 | 22.8 | GO:0005521 | lamin binding(GO:0005521) |
1.1 | 18.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.1 | 7.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.1 | 8.6 | GO:0004064 | arylesterase activity(GO:0004064) |
1.1 | 7.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.1 | 4.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.1 | 4.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.1 | 17.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.0 | 6.2 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
1.0 | 17.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
1.0 | 3.1 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
1.0 | 33.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.0 | 3.0 | GO:0036033 | mediator complex binding(GO:0036033) |
1.0 | 17.1 | GO:0043495 | protein anchor(GO:0043495) |
1.0 | 14.9 | GO:0070403 | NAD+ binding(GO:0070403) |
1.0 | 4.9 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
1.0 | 1.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.0 | 1.0 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
1.0 | 14.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
1.0 | 1.9 | GO:0097001 | ceramide binding(GO:0097001) |
1.0 | 3.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.9 | 2.8 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.9 | 2.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.9 | 2.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.9 | 3.6 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.9 | 11.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.9 | 33.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.9 | 18.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.9 | 4.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.9 | 8.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.9 | 2.6 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.9 | 3.5 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.9 | 25.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.9 | 4.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.9 | 8.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.9 | 2.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.9 | 3.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.9 | 2.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.8 | 5.8 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.8 | 18.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 5.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.8 | 2.4 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.8 | 6.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 45.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.8 | 11.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.8 | 16.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.8 | 55.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.8 | 17.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.8 | 13.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.7 | 93.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.7 | 13.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.7 | 2.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.7 | 14.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.7 | 2.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.7 | 2.2 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.7 | 7.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.7 | 18.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.7 | 147.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.7 | 4.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.7 | 17.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.7 | 10.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.7 | 6.0 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.7 | 7.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.7 | 11.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.6 | 9.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 6.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 2.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.6 | 15.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.6 | 11.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.6 | 7.7 | GO:0015926 | glucosidase activity(GO:0015926) |
0.6 | 43.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.6 | 10.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.5 | 9.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.5 | 11.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 5.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 2.1 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.5 | 2.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 35.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.5 | 5.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 3.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 8.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 12.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.5 | 9.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.5 | 2.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 1.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 13.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 3.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 6.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 9.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 7.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 1.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 13.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.4 | 7.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.4 | 12.7 | GO:0019956 | chemokine binding(GO:0019956) |
0.4 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 3.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 4.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 25.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.4 | 17.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 5.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 7.8 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.4 | 6.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.4 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 17.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.4 | 32.6 | GO:0042393 | histone binding(GO:0042393) |
0.4 | 6.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 7.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 3.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.3 | 4.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.3 | 7.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 4.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 5.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 1.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.3 | 13.4 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 1.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 2.2 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.3 | 1.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 2.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 23.9 | GO:0004386 | helicase activity(GO:0004386) |
0.3 | 10.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 2.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 2.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 2.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 14.0 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.3 | 7.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 5.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 2.9 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 50.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 74.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 14.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 1.0 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 2.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 1.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 3.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 7.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 1.6 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.2 | 9.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 16.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 20.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 1.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 2.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 2.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 5.5 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 0.7 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 1.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 4.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 1.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 1.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 6.8 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.5 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 2.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 1.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 5.0 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 19.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 2.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 5.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 3.0 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 7.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 3.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 1.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 3.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 4.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 3.8 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.6 | GO:0070915 | lysophosphatidic acid binding(GO:0035727) lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 56.9 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 5.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 1.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 2.2 | GO:0004672 | protein kinase activity(GO:0004672) |
0.1 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 12.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 1.0 | GO:0004629 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.0 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 1.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 1.0 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 138.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
2.6 | 76.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
2.4 | 82.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.1 | 30.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
2.1 | 52.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.9 | 188.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.9 | 46.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.8 | 38.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.8 | 222.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.7 | 94.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.7 | 87.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.6 | 16.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.5 | 57.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.5 | 26.3 | PID BARD1 PATHWAY | BARD1 signaling events |
1.4 | 51.4 | PID ALK1 PATHWAY | ALK1 signaling events |
1.4 | 114.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.4 | 5.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.3 | 10.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.3 | 132.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.3 | 13.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.2 | 3.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.2 | 91.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.2 | 33.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.2 | 58.9 | PID AURORA B PATHWAY | Aurora B signaling |
1.1 | 59.2 | PID P53 REGULATION PATHWAY | p53 pathway |
1.1 | 50.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.1 | 61.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.1 | 74.8 | PID CDC42 PATHWAY | CDC42 signaling events |
1.0 | 23.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.0 | 15.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.0 | 32.0 | PID RHOA PATHWAY | RhoA signaling pathway |
1.0 | 42.5 | PID PLK1 PATHWAY | PLK1 signaling events |
1.0 | 52.4 | PID E2F PATHWAY | E2F transcription factor network |
0.9 | 15.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.8 | 12.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.8 | 21.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.8 | 7.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 24.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.6 | 7.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 14.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 10.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 3.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 15.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 33.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 20.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 15.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 5.4 | PID ATM PATHWAY | ATM pathway |
0.3 | 5.4 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 6.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 20.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 10.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 4.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 5.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 4.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.5 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 2.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 1.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 10.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 4.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 9.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 5.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 127.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
6.3 | 56.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
4.6 | 59.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
4.3 | 68.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
4.0 | 68.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
3.7 | 162.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
3.6 | 61.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
3.3 | 49.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
2.8 | 62.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
2.6 | 82.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
2.4 | 148.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
2.4 | 152.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.3 | 356.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
2.2 | 15.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
2.2 | 17.5 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
1.9 | 65.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.8 | 23.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.8 | 18.3 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
1.7 | 39.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.7 | 59.7 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
1.6 | 55.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.6 | 7.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.5 | 31.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.5 | 54.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
1.4 | 10.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.4 | 61.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.4 | 143.9 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
1.4 | 103.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
1.3 | 12.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
1.3 | 8.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.2 | 34.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.2 | 24.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.2 | 17.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.1 | 28.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 19.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
1.1 | 24.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.1 | 25.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.1 | 22.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.1 | 26.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.0 | 11.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.9 | 11.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.9 | 1.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.9 | 21.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.9 | 68.2 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.9 | 27.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.8 | 28.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.8 | 21.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 9.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.8 | 15.6 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.8 | 12.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.8 | 35.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.8 | 6.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.8 | 27.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.8 | 26.9 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.8 | 29.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 5.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 5.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 26.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 3.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 15.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.6 | 40.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 7.9 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.6 | 3.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 6.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 12.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 15.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 5.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 2.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.5 | 68.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.5 | 29.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 55.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 4.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 10.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 7.9 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.4 | 4.6 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 3.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 5.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.4 | 3.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 16.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 6.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 4.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 3.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 4.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 11.7 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.3 | 7.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 7.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 9.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 41.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 10.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 4.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 2.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 10.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 5.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 1.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 4.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 4.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 10.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 2.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 2.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 2.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 5.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 4.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 1.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 6.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 5.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.6 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |